1 | 08:45-09:20 | 议题 |
关于HPV检测:是否应该推广自采样?是否应该推广载量检测? |
|
||||||||||||
2 | 09:20-09:55 | 议题 |
中老年女性是否应该进行HPV疫苗接种? |
|
||||||||||||
3 | 09:55-10:30 | 议题 |
宫颈高级别病变锥切术前后是否应该接种HPV疫苗? |
|
1 | 11:00-11:05 | 论文发言 |
Exploring molecular heterogeneity and therapeutic targets of metastatic/recurrent cervical cancer based on deep analysis of large panel genes |
|
||||
2 | 11:05-11:10 | 论文发言 |
Genome-wide and Multi-omics Mapping of HPV Integration Signatures in Cervical Pre-Invasive and Invasive disease |
|
||||
3 | 11:10-11:15 | 论文发言 |
Preliminary Study on Prediction of Immune Microenvironment and Prognosis of Cervical Cancer Patients Based on MRI Radiomics before Treatment |
|
||||
4 | 11:15-11:20 | 论文发言 |
CS Ratio is an immune-related prognostic biomarker for cervical cancer |
|
||||
5 | 11:20-11:25 | 论文发言 |
宫颈癌中等分割在线自适应放疗的疗效及安全性分析:一项前瞻性单臂I期临床研究 |
|
||||
6 | 11:25-11:30 | 论文发言 |
CIN3外切缘阳性与进一步切子宫后的HPV延迟清除有关 |
|
||||
7 | 11:30-11:35 | 论文发言 |
ZBTB5 enhances the resistance of cervical cancer to paclitaxel by regulating BCL6 |
|
||||
8 | 11:35-11:40 | 论文发言 |
Effect of laparoscopic para-aortic and pelvic lymphadenectomy for patients with FIGO stage IIb-IIIC cervical cancer before CCRT:A single-center retrospective study |
|
||||
9 | 11:40-11:45 | 论文发言 |
宫颈癌前哨淋巴结不同转移对预后的影响:一项多中心真实世界回顾性研究 |
|
||||
10 | 11:50-12:00 |
讨论交流 |
1 | 13:00-13:30 | 专题会发言 |
双抗在宫颈癌的治疗进展和展望 |
|
1 | 13:30-13:38 | 引导报告 |
子宫颈癌手术的术式变迁 |
|
||||
2 | 13:38-13:46 | 引导报告 |
保留神经的广泛性子宫切除手术 |
|
||||
3 | 13:46-13:54 | 引导报告 |
子宫颈癌的微创手术相关问题 |
|
||||
4 | 13:54-14:02 | 引导报告 |
膜解剖下输尿管游离和宫颈旁组织切除 |
|
||||
5 | 14:02-14:10 | 引导报告 |
早期子宫颈癌前哨淋巴结活检相关问题 |
|
||||
6 | 14:10-14:18 | 引导报告 |
子宫颈癌手术中泌尿/直肠损伤问题 |
|
||||
7 | 14:18-15:30 |
讨论 |
1 | 15:30-16:00 | 专题会发言 |
从传统疗法到精准靶向——最适合复发或转移性宫颈癌的二线系统治疗方案 |
|
1 | 16:00-16:07 | 引导报告 |
外阴癌手术原则与辅助治疗 |
|
||||||||||||||
2 | 16:07-16:14 | 引导报告 |
阴道癌治疗原则与治疗困惑 |
|
||||||||||||||
3 | 16:14-16:21 | 引导报告 |
生殖道黑色素瘤的治疗 |
|
||||||||||||||
4 | 16:21-17:00 |
讨论 |
|
1 | 17:00-17:05 | 论文发言 |
Targeting Cervical Small Cell Neuroendocrine Carcinoma: A High-Throughput Drug Screening Approach Using Organoids |
|
||||
2 | 17:05-17:10 | 论文发言 |
TNFA在宫颈癌前病变演变中的作用及微生物驱动机制研究 |
|
||||
3 | 17:10-17:15 | 论文发言 |
68Ga-THP-NB1 PET/CT在晚期/复发性宫颈癌患者中PDL1表达的显像效果 |
|
||||
4 | 17:15-17:20 | 论文发言 |
HMGA2调控DNA损伤修复通路介导宫颈癌放疗抵抗的机制研究 |
|
||||
5 | 17:20-17:25 | 论文发言 |
替雷利珠单抗联合新辅助化疗治疗局部晚期宫颈癌的有效性及安全性研究 |
|
||||
6 | 17:25-17:30 | 论文发言 |
对巨块型宫颈癌发生宫旁浸润的影响因素及其治疗决策的探索 |
|
||||
7 | 17:30-17:35 | 论文发言 |
前哨淋巴结活检应用于早期宫颈癌的回顾性队列研究 |
|
||||
8 | 17:35-17:40 | 论文发言 |
ICCOR: Integrative Cervical Cancer Omics Resource |
|
||||
9 | 17:40-17:45 | 论文发言 |
Establishment of Patient-Derived Organoids for Gastric-Type Endocervical Adenocarcinoma |
|
||||
10 | 17:45-17:50 | 论文发言 |
Precision oncology guided by causal inference: Integrative multi-omics Mendelian randomization reveals immune-epigenetic crosstalk driving cervical carcinogenesis |
|
||||
11 | 17:50-18:00 |
讨论交流 |
1 | 19:00-19:10 | 视频展示 |
外阴癌皮瓣移植新思路 |
|
||||
2 | 19:10-19:20 | 视频展示 |
以最小创伤,谋最大获益——腹股沟淋巴结切除的腔镜解决方案 |
|
||||
3 | 19:20-19:30 | 视频展示 |
卵巢癌腹壁复发灶切除联合阔筋膜腹壁筋膜修补术一例 |
|
||||
4 | 19:30-19:40 | 视频展示 |
卵巢癌膈肌及心包肿瘤切除后膈肌修补术 |
|
||||
5 | 19:40-19:50 | 视频展示 |
全盆脏器切除手术视频 |
|
||||
6 | 19:50-20:00 | 视频展示 |
板状包绕型腹膜后淋巴结切除 |
|
1 | 20:00-20:10 | 视频展示 |
宫颈癌放疗后复发腹腔镜后盆腔脏器廓清术 |
|
||||
2 | 20:10-20:20 | 视频展示 |
复发性宫颈癌手术 |
|
||||
3 | 20:20-20:30 | 视频展示 |
破膈攻坚--膈肌病灶及心膈角淋巴结切除 |
|
||||
4 | 20:30-20:40 | 视频展示 |
静脉内平滑肌瘤手术分享 |
|
||||
5 | 20:40-20:50 | 视频展示 |
腹腔镜下宫旁广泛切除术 |
|
||||
6 | 20:50-21:00 | 视频展示 |
腹腔镜改良QM-C1型子宫切除术在早期宫颈癌中的优势 |
|
1 | 21:00-21:10 | 视频展示 |
隐匿性阴道直肠隔病灶切除 |
|
||||
2 | 21:10-21:20 | 视频展示 |
盆腔血管内平滑肌瘤R0切除术 |
|
||||
3 | 21:20-21:30 | 视频展示 |
磁牵引技术在妇科手术中的应用及发展前景 |
|
||||
4 | 21:30-21:40 | 视频展示 |
腹腔镜全阴道切除及前庭大腺肿物切除 |
|
||||
5 | 21:40-21:50 | 视频展示 |
卵巢癌超根治之肝门淋巴结切除术 |
|
||||
6 | 21:50-22:00 | 视频展示 |
机器人辅助腹腔镜下改良广泛子宫切除术 |
|